Abstract：In the present report, cyclin-dependent kinase1 (CDK1) siRNA was transfected into cells to silence the CDK1 gene expression and study its role in the cell cycle and cell apoptosis. The siRNA targeting CDK1 gene was chemically synthesized and transfected into Hela cells by lipofectamine 2000. The expression levels of CDK1 gene and protein were examined by real-time quantitative polymerase chain reaction (PCR) and Western blot, respectively. The cell cycle was analyzed by using DNA content analysis by flow cytometry. Cell apoptosis was detected by the Annexin V/PI method. The morphological changes of transfected cells were examined under the microscopy by Wright-Giemsa stain. CDK1 gene was successfully silenced by its siRNA, and the CDK1 protein expression level was decreased significantly, especially from 48thh to 60thh after transfection. The DNA content analysis showed that transfection of CDK1 siRNA led to cells accumulating in G2/M phase. There was no significant difference in the apoptotic rate between transfected cells and the control cells after transfection of CDK1 siRNA for 48 or 60h. More double nucleus or multinucleus cells could be seen under the microscopy among the transfected cells. The decreased CDK1 expression by siRNA silencing gave rise to cell cycle arrest in G2/M phase but did not induce apoptosis.
. The role of CDK1 siRNA interference in cell cycle
and cell apoptosis[J]. Front. Med., 2009, 3(4): 384-389.
Hui XIAO PhD, Ming TIAN MM, Junna GE MM, Xin Wei MD, Zhaoming LI MM, Xiaolan LI MS, Deding TAO PhD, Junbo HU MD, Jianping GONG MD, . The role of CDK1 siRNA interference in cell cycle
and cell apoptosis. Front. Med., 2009, 3(4): 384-389.
Evan G I, Vousden K H. Proliferation, cell cycleand apoptosis in cancer. Nature, 2001, 411(6835): 342―349 doi: 10.1038/35077213
Blagosklonny M V. Apoptosis, proliferation, differentiation: in search of the order. Semin Cancer Biol, 2003, 13(2): 97―105 doi: 10.1016/S1044-579X(02)00127-X
Park M T, Lee S J. Cell cycle and cancer. J Biochem Mol Biol, 2003, 36(1): 60―65
Karin M, Lin A. NF-κB at the crossroadsof life and death. Nat Immunol, 2002, 3(3): 221―227 doi: 10.1038/ni0302-221
Maddika S, Ande S R, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda K D, Wiechec E, Los M. Cell survival,cell death and cell cycle pathways are interconnected: implicationsfor cancer therapy. Drug Resist Updat, 2007, 10(1,2): 13―29
Morgam D O. Principles of CDK regulation. Nature, 1995, 374(6518): 131―134 doi: 10.1038/374131a0
Nurse P. Universalcontrol mechanism regulating onset of M phase. Nature, 1990, 344(6266): 503―508 doi: 10.1038/344503a0
Harlow E, Lane D. Antibodies: A LaboratoryManual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1988, 450
Valcourt U, Gouttenoire J, Moustakas A, Herbage D, Mallein-Gerin F. Functions of transforminggrowth factor-beta family type I receptors and Smad proteins in thehypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem, 2002, 277(37): 33545―33558 doi: 10.1074/jbc.M202086200
Kirou K A, Lee C, George S, Louca K, Papagiannis I G, Peterson M G, Ly N, Woodward R N, Fry K E, Lau A Y, Prentice J G, Wohlgemuth J G, Crow M K. Coordinateoverexpression of interferon-alpha-induce- genes in systemic lupuserythematosus. Arthritis Rheum, 2004, 50(12): 3958―3967 doi: 10.1002/art.20798
Kirou K A, Lee C, Crow M K. Measurement of cytokines in autoimmune disease. Methods Mol Med, 2004, 102: 129―154
Koopman G, Reutelingsperger C P, Kuijten G A, Keehnen R M, Pals S T, van Oers M H. Annexin V for flow cytometricdetection of phosphatidylserine expression of B cells undergoing apoptosis. Blood, 1994, 84(5): 1415―1420
Fadok V A, Voelker D R, Cammpbell P A, Cohen J J, Bratton D L, Henson P M. Exposure of phosphatidylserine on the surface of apoptoticlymphocytes triggers specific recognition and removal by macrophages. J Immunol, 1992, 148(7): 2207―2216
Bühler M, Moazed D. Transcription and RNAi inheterochromatic gene silencing. Nat StructMol Biol, 2007, 14(11): 1041―1048 doi: 10.1038/nsmb1315
Scoazec J Y. The RNA revolution. Ann Pathol, 2006, 26(4): 2752―2780
Ying S Y, Chang D C, Miller J D, Lin S L. The microRNA:overview of the RNA gene that modulates gene functions. Methods Mol Biol, 2006, 342: 1―18
Zender L, Kubicka S. SiRNA based strategies forinhibition of apoptotic pathways in vivo-analytical and therapeuticimplications. Apoptosis, 2004, 9(1): 51―54 doi: 10.1023/B:APPT.0000012121.52210.23
Shi L, Nishioka W K, Th'ng J, Bradbury E M, Litchfield D W, Greenbergl A H. Premature p34cdc2 activation required for apoptosis. Science, 1994, 263(5150): 1143―1145 doi: 10.1126/science.8108732
Hahntow I N, Schneller F, Oelsner M, Weick K, Ringshausen I, Fend F, Peschel C, Decker T. Cyclin-dependent kinase inhibitorroscovitine induces apoptosis in chronic lymphocytic leukemia cells. Leukemia, 2004, 18(4): 747―755 doi: 10.1038/sj.leu.2403295
Golsteyn R M. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis:a role beyond the cell cycle. Cancer Lett, 2005, 217(2): 129―138 doi: 10.1016/j.canlet.2004.08.005
Rideout H J, Wang Q, Park D S, Stefanis L. Cyclin-dependentkinase activity is required for apoptotic death but not inclusionformation in cortical neurons after proteasomal inhibition. J Neurosci, 2003, 23(4): 1237―1245
Gartel A L. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res, 2005, 29(11): 1237―1238 doi: 10.1016/j.leukres.2005.04.023
Davido D J, Leib D A, Schaffer P A. The cyclin-dependent kinase inhibitor roscovitine inhibitsthe transactivating activity and alters the posttranslational modificationof herpes simplex virus type 1 ICP0. JVirol, 2002, 76(3): 1077―1088
Edamatsu H, Gau C L, Nemoto T, Tamanoi F. Cdkinhibitors, roscovitine and olomoucine, synergize with farnesyltransferaseinhibitor (FTI) to induce efficient apoptosis of human cancer celllines. Oncogene, 2000, 19(27): 3059―3068 doi: 10.1038/sj.onc.1203625
Alvi A J, Austen B, Weston V J, Fegan C, Maccallum D, Gianella-Borradori A, Lane D P, Hubank M, Powell J E, Wei W, Taylor A M, Moss P A, Stankovic T. A novel CDK inhibitor, CYC202(R-roscovitine), overcomes the defect in p53-dependent apoptosis inB-CLL by down-regulation of genes involved in transcription regulationand survival. Blood, 2005, 105(11): 4484―4491 doi: 10.1182/blood-2004-07-2713
